About 200 MG Sorafenib Tablets
The 200 MG Sorafenib Tablets are useful for the effective treatment of various types of cancer. Useful for a targeted therapy, these can be used as Angiogenesis Inhibitor, tyrosine Kinase inhibitor and VEGF inhibitor. Offered medicates are suited for the treatment of advanced renal cell cancer, thyroid cancer and hepatocellular carcinoma (HCC). Provided 200 MG Sorafenib Tablets are prescribed by the experts and are taken before the meal. The medicine is made to block the growth of tumor cell in many ways. These medicines are safe for all ages and are demanded in hospitals as well as other medical provisions.
Specification
|
Brand
|
Soranib
|
|
Dose
|
200mg
|
|
Packaging Size
|
30 Tablet
|
|
Packaging Type
|
Box
|
|
Usage
|
Clinical
|
|
Manufactured By
|
Cipla
|
Powerful Multi-Kinase Inhibition for Cancer TherapySorafenib Tablets provide an advanced approach to cancer management by targeting multiple kinases involved in cancer growth and spread. This multi-kinase inhibitor is recommended for advanced stages of renal cell carcinoma, liver cancer, and certain thyroid cancers. By disrupting crucial processes in tumor cells, Sorafenib helps slow disease progression, offering valuable benefits as part of a prescribed oncology regimen.
Quality Assurance and Reliable PackagingEach 200 mg tablet is stored in Alu-Alu blister packs, safeguarding against moisture and contamination. The packaging helps maintain the products efficacy throughout its 36-month shelf life. Backed by approvals from leading regulatory authorities and stringent manufacturing quality, patients and healthcare professionals can rely on Sorafenibs consistent performance and safety profile.
FAQs of 200 MG Sorafenib Tablets:
Q: How should 200 mg Sorafenib Tablets be taken for optimal effectiveness?
A: Sorafenib Tablets should be swallowed whole with water, preferably without food or as directed by your physician. Consistent oral administration at the same time each day improves therapeutic outcomes, but always follow your doctors specific instructions for dosage and duration.
Q: What conditions are treated with Sorafenib 200 mg Tablets?
A: These tablets are primarily prescribed for advanced renal cell carcinoma, hepatocellular carcinoma, and differentiated thyroid cancer. Your healthcare provider will evaluate whether Sorafenib is appropriate for your type of cancer and disease stage.
Q: When is Sorafenib contraindicated?
A: Sorafenib should not be used by individuals with known hypersensitivity to Sorafenib or any excipients in the tablet, such as microcrystalline cellulose and croscarmellose sodium. Always consult your physician about your medical history before starting treatment.
Q: Where should Sorafenib Tablets be stored to preserve their quality?
A: Store the tablets below 30C, away from light and moisture, in their original Alu-Alu blister packaging. Proper storage extends the shelf life to 36 months and maintains the medications integrity.
Q: What regulatory approvals support the use of Sorafenib Tablets?
A: Sorafenib is approved by major health regulatory authorities. Specific approval details are indicated on the packaging. The product meets stringent safety and efficacy standards for prescription-only cancer therapy in India and other jurisdictions.
Q: What are the benefits of using Sorafenib as a multi-kinase inhibitor?
A: Sorafenib targets various kinases that contribute to tumor growth and progression, helping to slow cancer cell proliferation. It offers a multi-faceted approach to treatment, potentially improving patient outcomes in cases of advanced cancers as indicated by your oncologist.